BeOne Medicines (ONC) Tax Provisions (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Tax Provisions data on file, last reported at $31.9 million in Q1 2026.

• On a quarterly basis, Tax Provisions rose 62.29% year-over-year to $31.9 million in Q1 2026; TTM through Mar 2026 was $142.1 million, a 14.92% increase from a year earlier, with the FY2025 full-year figure at $129.9 million, up 16.22% from the prior year.
• Tax Provisions for Q1 2026 stood at $31.9 million, down from $82.7 million in the prior quarter.
• Over the last five years, Tax Provisions for ONC reached as high as $82.7 million in Q4 2025 and fell as low as $5.2 million in Q2 2025.
• Historically, Tax Provisions has averaged $21.9 million across 5 years, with a median of $14.4 million in 2022.
• Across the five-year window, Tax Provisions surged 3639.57% in 2022 and slumped 63.9% in 2025, its largest moves.
• Year by year, Tax Provisions stood at $14.4 million in 2022, then gained by 16.78% to $16.8 million in 2023, then jumped by 296.46% to $66.5 million in 2024, then gained by 24.36% to $82.7 million in 2025, then slumped by 61.5% to $31.9 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $31.9 million in Q1 2026, $82.7 million in Q4 2025, and $22.3 million in Q3 2025.